According to a release issued by the governor's office, BD will add 274 new jobs during the next five years (182 in Durham and 92 in Wilson) and invest $134.7 million. The projects were made possible in part by a Job Development Investment Grant.
"BD's presence is another example of why North Carolina has been consistently ranked among the top three states in biotechnology and life sciences," Easley said. "This announcement shows that our efforts in education and job training keep North Carolina a nationally recognized leader in the pharmaceutical and healthcare industries."
BD manufactures and sells medical devices and instrument systems.
The New Jersey-based company currently has three facilities in Durham County, where it employs 578 workers, including 70 at a BD Diagnostics-TriPath facility. BD acquired TriPath Imaging in 2006. BD also operates a former TriPath facility in Burlington that employs more than 100 workers.
While individual wages will vary by job duties for the 274 new jobs, the average pay for the newly created positions, not including benefits, is expected to exceed $46,000 a year for the Wilson jobs and almost $54,000 a year for the Durham jobs.
"Worldwide demand for BD's products is continuing to grow and we are expanding to meet that demand," said Johnathan Macy, BD senior vice president for integrated supply chain. "We could not be more pleased to be expanding in North Carolina. The spirit of public-private partnership here, combined with the skilled workforce and infrastructures we depend on, have allowed us to deepen our commitment to a region that over 700 BD associates already call home."
For more information about BD, including employment opportunities, visit www.bd.com.
